Malignant mesothelioma as a difficult interdisciplinary problem

Our plain-English summary of Malignant mesothelioma as a difficult interdisciplinary problem, by W. Rokicki, M. Rokicki, J. Wojtacha, et al (Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-thoracic Surgery, 2017).

The study

• Authors: W. Rokicki, M. Rokicki, J. Wojtacha, M.K. Rydel
• Journal: Kardiochirurgia I Torakochirurgia Polska = Polish Journal of Cardio-thoracic Surgery
• Published: 2017;14(4):263-267
• Type of article: Review
• Cited by: 3 articles, as counted by NIH iCite
• Read it: PubMed · Publisher · Free full text

Abstract

The authors of the present report review the etiology and clinical symptoms of malignant pleural mesothelioma (MPM) as well as diagnostic techniques (both radiological and biomarkers) used for its detection. Subsequently, they present methods of multimodal treatment (surgery, chemotherapy, and radiotherapy) recommended by the International Mesothelioma Interest Group (IMIG). Finally, they discuss complications and long-term results associated with these methods of MPM treatment.

In plain English

This article was a review paper and collected no patient data of its own. It summarized published literature on malignant pleural mesothelioma: causes, symptoms, diagnosis, blood markers, International Mesothelioma Interest Group (IMIG) staging, and treatment with surgery, chemotherapy and radiation therapy. Drawing on cited sources, the review described asbestos inhalation as a cause of the disease. It stated that the time from first asbestos exposure to symptoms may last 25–71 years, and that asbestos exposure is not confirmed in approximately 20% of patients. It described the current view that simian virus 40 (SV40) does not play an important role. Citing earlier work, it gave median survival of 10–35 months after extrapleural pneumonectomy with multimodal therapy, 8–20 months after pleurectomy/decortication with multimodal therapy, and 9.3–13.3 months with chemotherapy alone. It noted that the cited authors disagreed on which operation gives better results. It also stated that fully radical (R0) resection is practically impossible and that the efficacy of photodynamic therapy remains largely unknown. The authors gave no separate overall conclusion and did not discuss limitations of the review itself.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: narrative review of published literature (no new patient data)
• Who was studied: No study population; the review covered published literature on malignant pleural mesothelioma (MPM)
• Exposure: Asbestos exposure, described from cited literature as a cause of MPM; no specific fiber types or products were analysed
• Main results:
  • Citing earlier literature, the review stated that the latency period between initial asbestos exposure and clinical symptoms may last 25–71 years
  • The review stated that examinations fail to confirm asbestos exposure in approximately 20% of MPM patients
  • Citing earlier literature, the review described the current view that SV40 virus does not play an important role in MPM development
  • Citing earlier literature, the review stated that the epithelioid type is found in 50–57% of patients and is the most common form
  • Citing earlier work, the review gave median survival of 10–35 months after extrapleural pneumonectomy combined with multimodal therapy
  • Citing earlier work, the review gave median survival of 8–20 months after pleurectomy with decortication and multimodal therapy
  • Citing earlier work, the review gave median survival of 9.3–13.3 months among patients treated with chemotherapy alone
  • The review noted that cited authors disagree when comparing extrapleural pneumonectomy with pleurectomy/decortication
  • The review stated that resection that is both macro- and microscopically radical (R0) is practically impossible because of the lack of surgical margins
  • The review stated that the efficacy of photodynamic therapy in treating MPM remains largely unknown

Topics

Medical terms in this study, explained in our Lexicon: Mesothelioma, Etiology, Pleural Mesothelioma, Biomarker, Chemotherapy, IMIG.

Related studies

• Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy — P. Star, A. Goodwin, et al. (2018)
• An interdisciplinary approach to measurement — (1969)
• Is there a need for expert opinion for biopsy diagnosis of difficult cases of malignant mesothelioma? — S. Klebe, K.M. Griggs, et al. (2012)
• Difficult to Identify: Malignant Primary Peritoneal Mesothelioma — B.S. Zha, M. Flanagan, et al. (2015)
• Primary malignant pericardial mesothelioma with difficult antemortem diagnosis: A case report — N. Oka, Y. Orita, et al. (2022)
• Rapamycin Treatment for Benign Multicystic Peritoneal Mesothelioma: A Rare Disease with a Difficult Management — G. Stallone, B. Infante, et al. (2017)

Browse return to medical research.